Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
March 5, 2007
- Mochida Joins Novartis to Promote Diovan
March 5, 2007
- NEW PRODUCT
February 26, 2007
- METI to Start Health Information Platform Initiative
February 26, 2007
- Kyowa Hakko Achieves Personnel Cost Cutting Target Ahead of Schedule
February 26, 2007
- JPA Working Out Clear Position Toward Promotion of GE Drugs
February 26, 2007
- Intage Surveying Doctors on MR Calls and Their Impact
February 26, 2007
- No Marked Rise in Share of Generics from Jun. to Oct. 2006
February 26, 2007
- BUSINESS NEWS IN BRIEF
February 26, 2007
- Toyama Prefecture Tests Generics from Makers Under Its Control
February 26, 2007
- SEMINAR
February 26, 2007
- TOPIC about Novo Nordisk Pharma
February 26, 2007
- Regulatory Systems in Japan Need Improvements in 5 Areas: Mr Dunoyer of EFPIA Japan
February 26, 2007
- Pfizer J-GAP Survey
February 26, 2007
- New Review, Consultation Fees Proposed
February 26, 2007
- DSP Is Seeing Synergistic Effects: President Miyatake
February 26, 2007
- Toxicogenomics Research Project
February 26, 2007
- CMIC to Go to the West to Promote Japan-Centered Clinical Trials
February 26, 2007
- R&D NEWS IN BRIEF
February 26, 2007
- Roche Diagnostics Aims for 7.1% Growth in Sales in Bearish Market
February 26, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…